PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
13-Aug-2025 Aspira Announces Second Quarter 2025 Financial Results and Provides Business Update ACCESS Newswire
13-Aug-2025 Medios accelerates growth in the first half of 2025 and significantly increases earnings Medios AG
13-Aug-2025 Straumann Group delivers strong first half and confirms full-year 2025 outlook Straumann Holding AG
13-Aug-2025 Evotec SE reports H1 2025 results: Strong progress on strategy execution Evotec SE
13-Aug-2025 Formycon confirms full-year guidance following business development in line with plan – working capital raised Formycon AG
13-Aug-2025 Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution ACCESS Newswire
12-Aug-2025 eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today ACCESS Newswire
12-Aug-2025 ClearPoint Neuro Reports Second Quarter 2025 Results ACCESS Newswire
12-Aug-2025 Black Book: Cloud Transformation Now Core to Provider Growth Strategies in $275B Market Expansion ACCESS Newswire
12-Aug-2025 Dr. Roy Levitt, Executive Chairman of Adolore BioTherapeutics, Presented at the Next Generation Gene Therapy Vectors Summit ACCESS Newswire
12-Aug-2025 Veterinary Referral Center of Central Oregon Expands Life-Saving Treatment Options With Extracorporeal Therapies ACCESS Newswire
12-Aug-2025 VSee Health Appeals NASDAQ Staff Delisting Notice ACCESS Newswire
12-Aug-2025 PureTech Announces the Launch of Celea Therapeutics with a Mission to Transform the Treatment of Respiratory Diseases PureTech
12-Aug-2025 Panthera Biopartners secures investment from LDC to accelerate expansion Panthera Biopartners
12-Aug-2025 FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response FoRx Therapeutics
12-Aug-2025 FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy Tiziana Life Sciences
12-Aug-2025 LIEBHERR LAUNCHES NEW UNDER-BENCH FRIDGE AND FREEZERS FOR LABORATORY AND HEALTHCARE PROVIDERS LIEBHERR
12-Aug-2025 PureTech Announces the Launch of Celea Therapeutics with a Mission to Transform the Treatment of Respiratory Diseases Celea Therapeutics
12-Aug-2025 RNA-Based Therapeutics for Hearing Restoration Market to Reach $430 Million by 2032, Driven by Breakthrough Clinical Trials and Expanding Indications globenewswireonlione
12-Aug-2025 Discover How Aletheia Strengthens Your Hospital's HR ACCESS Newswire